In vitro evaluation of the clinical utility of Apitolisib/Vorinostat combination in Apitolisib-resistant H1975 lung adenocarcinoma cells

Authors: Abduladim Hmmier, Paul Dowling

Source: Future Journal of Pharmaceutical Sciences, Vol 10, Iss 1, Pp 1-10 (2024)

Subject Terms: H1975 lung adenocarcinoma, Apitolisib-acquired resistance, Acquired aggressive proliferation, Metabolic reprogramming, Apitolisib/Vorinostat combination, Therapeutics. Pharmacology, RM1-950, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://doaj.org/toc/2314-7253

Access URL: https://doaj.org/article/9e4cd27a9c7d4f3aa45a2f3d06206ab1